Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Matt Bush

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, Capital Markets, corporate
Office
San Diego
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPOM&AVenture Capital & Growth
Sectors
Financial ServicesHealthcare & Life Sciences
Jurisdictions
CaliforniaNasdaqSingaporeUnited States

Recent deals

37 announced deals in the record
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 446m Lead Capital Markets San Diego
Latham Advises on Viking Therapeutics’ Upsized US$500 Million Offering of Common Stock and Convertible Senior Notes 25 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 500m Capital Markets San Diego
Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering 21 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 350m Lead Capital Markets San Diego
Latham & Watkins Advises Tyra on US$400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants 17 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 400m Lead corporate
Latham & Watkins Advises on Oversubscribed US$150 Million Private Placement in Connection With Werewolf Therapeutics and Ambros Therapeutics’ Reverse Merger Transaction 24 Aug 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead corporate San Diego
Latham Advises Gossamer Bio on Up to US$250 Million Structured Private Placement, Including US$150 Million of Committed Capital 21 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 250m Lead corporate San Diego
Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger 18 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 245m Lead corporate San Diego
Latham Advises on MapLight Therapeutics’ US$150 Million Private Placement Financing 15 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead corporate
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO 10 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead Capital Markets San Diego
Latham & Watkins Advises Erasca on US$550 Million Upsized Public Offering of Common Stock 15 Jul 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 550m Lead corporate San Diego
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Matt Bush is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 37 deals for Matt Bush

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction